Your browser doesn't support javascript.
loading
A Comprehensive Analysis of Hungarian MODY Patients-Part I: Gene Panel Sequencing Reveals Pathogenic Mutations in HNF1A, HNF1B, HNF4A, ABCC8 and INS Genes.
Gaál, Zsolt; Szucs, Zsuzsanna; Kántor, Irén; Luczay, Andrea; Tóth-Heyn, Péter; Benn, Orsolya; Felszeghy, Eniko; Karádi, Zsuzsanna; Madar, László; Balogh, István.
  • Gaál Z; 4th Department of Medicine, Jósa András Teaching Hospital, 4400 Nyíregyháza, Hungary.
  • Szucs Z; Division of Clinical Genetics, Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
  • Kántor I; Department of Pediatrics, Jósa András Teaching Hospital, 4400 Nyíregyháza, Hungary.
  • Luczay A; 1st Department of Pediatrics, Semmelweis University, 1085 Budapest, Hungary.
  • Tóth-Heyn P; 1st Department of Pediatrics, Semmelweis University, 1085 Budapest, Hungary.
  • Benn O; Department of Pediatrics, Szent György Hospital of Fejér County, 8000 Székesfehérvár, Hungary.
  • Felszeghy E; Department of Pediatrics, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
  • Karádi Z; Department of Pediatrics, Szent György Hospital of Fejér County, 8000 Székesfehérvár, Hungary.
  • Madar L; Division of Clinical Genetics, Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
  • Balogh I; Division of Clinical Genetics, Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Life (Basel) ; 11(8)2021 Jul 27.
Article en En | MEDLINE | ID: mdl-34440499
ABSTRACT
Maturity-onset diabetes of the young (MODY) has about a dozen known causal genes to date, the most common ones being HNF1A, HNF4A, HNF1B and GCK. The phenotype of this clinically and genetically heterogeneous form of diabetes depends on the gene in which the patient has the mutation. We have tested 450 Hungarian index patients with suspected MODY diagnosis with Sanger sequencing and next-generation sequencing and found a roughly 30% positivity rate. More than 70% of disease-causing mutations were found in the GCK gene, about 20% in the HNF1A gene and less than 10% in other MODY-causing genes. We found 8 pathogenic and 9 likely pathogenic mutations in the HNF1A gene in a total of 48 patients and family members. In the case of HNF1A-MODY, the recommended first-line treatment is low dose sulfonylurea but according to our data, the majority of our patients had been on unnecessary insulin therapy at the time of requesting their genetic testing. Our data highlights the importance of genetic testing in the diagnosis of MODY and the establishment of the MODY subtype in order to choose the most appropriate treatment.
Palabras clave